TrialThe international journal of neuropsychopharmacology2019
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Maggie Fedgchin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
208 papers cite itlatest 60 shown
this paperpooled ittrialcites it